Company Name: Merus N.V.
Merus B.V. is a clinical stage immuno-oncology company. The company is engaged in the development of bispecific antibody therapeutics. The company’s developmental pipeline includes treatments for solid and hematological tumors.
Ticker Symbol: MRUS (NASDAQ)
Company Website: www.merus.nl
Social Media: Merus LinkedIn Page
Headquarters: Utrecht, the Netherlands